Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 41.

Wild, P J; Kristiansen, G (2017). Sitzungsbericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie 2017. Der Pathologe, 38(Suppl 2):245-246.

Wild, P J; Kristiansen, G (2016). Sitzungsbericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie 2016. Der Pathologe, 37(Suppl 2):256-257.

Wild, P J (2013). p53 unterdrückt die Bildung von Typ-II-Endometriumkarzinomen im Mausmodell und ist ein unabhängiger negativer Prognosefaktor bei Patientinnen mit Endometriumkarzinom. In: 97. Jahrestagung der Deutschen Gesellschaft für Pathologie, Heidelberg, 23 May 2013 - 26 May 2013, 180-188.

Gerhardt, J; Montani, M; Wild, P J; Beer, M; Huber, F; Hermanns, T; Müntener, M; Kristiansen, G (2012). FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. American Journal of Pathology, 180(2):848-861.

Beer, M; Montani, M; Gerhardt, J; Wild, P J; Hany, T F; Hermanns, T; Müntener, M; Kristiansen, G (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates. Prostate, 72(3):318-325.

Eichwald, C; Arnoldi, F; Laimbacher, A; Schraner, E M; Fraefel, C; Wild, P J; Burrone, O R; Ackermann, M (2012). Rotavirus Viroplasm Fusion and Perinuclear Localization Are Dynamic Processes Requiring Stabilized Microtubules. PLoS ONE, 7(10):e47947.

Brookman-May, S; May, M; Zigeuner, R; Shariat, S F; Scherr, D S; Chromecki, T; Moch, H; Wild, P J; Mohamad-Al-Ali, B; Cindolo, L; Wieland, W F; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, M P; Burger, M; Pahernik, S (2011). Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. Journal of Urology, 186(6):2175-2181.

Nordentoft, I; Dyrskjøt, L; Bødker, J S; Wild, P J; Hartmann, A; Bertz, S; Lehmann, J; Orntoft, T F; Birkenkamp-Demtroder, K (2011). Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. BMC Cancer, 11:135.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Otto, W; Fritsche, H M; Wild, P J; Wieland, W F; Hartmann, A; Burger, M; Hofstädter, F; Denzinger, S (2011). Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder. Pathology, Research and Practice, 207(3):161-163.

Wild, P J. Molecular Biomarkers for Bladder Cancer: Implications for Prognosis, Therapy & Classification of the Disease. 2010, University of Zurich, Faculty of Medicine.

Leuenberger, M; Frigerio, S; Wild, P J; Noetzli, F; Korol, D; Zimmermann, D R; Gengler, C; Probst-Hensch, N M; Moch, H; Tinguely, M (2010). AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations. Modern Pathology, 23(2):177-186.

Meyer, S; Vogt, T; Landthaler, M; Berand, A; Reichle, A; Bataille, F; Marx, A H; Menz, A; Hartmann, A; Kunz-Schughart, L A; Wild, P J (2010). Cyclooxygenase 2 (COX2) and peroxisome proliferator-activated receptor gamma (PPARG) are stage-dependent prognostic markers of malignant melanoma. PPAR research, 2010:848645.

Schimanski, S; Wild, P J; Treeck, O; Horn, F; Sigruener, A; Rudolph, C; Blaszyk, H; Klinkhammer-Schalke, M; Ortmann, O; Hartmann, A; Schmitz, G (2010). Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, 42(2):102-109.

Raman, S; Fuchs, T J; Wild, P J; Dahl, E; Buhmann, J M; Roth, V (2010). Infinite mixture-of-experts model for sparse survival regression with application to breast cancer. BMC Bioinformatics, 11(Suppl 8):S8.

Owen, H C; Giedl, J; Wild, P J; Fine, S W; Humphrey, P A; Dehner, L P; Amin, M B; Epstein, J I; Blaszyk, H; Hughes, D; Hartmann, A; Stoehr, R; Catto, J W (2010). Low frequency of epigenetic events in urothelial tumors in young patients. The Journal of Urology, 184(2):459-463.

Meyer, S; Wild, P J; Vogt, T; Bataille, F; Ehret, C; Gantner, S; Landthaler, M; Klinkhammer-Schalke, M; Hofstaedter, F; Bosserhoff, A K (2010). Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Experimental Dermatology, 19(8):e251-e257.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

Amann, T; Bataille, F; Spruss, T; Dettmer, K; Wild, P J; Liedtke, C; Mühlbauer, M; Kiefer, P; Oefner, P J; Trautwein, C; Bosserhoff, A K; Hellerbrand, C (2010). Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. American Journal of Pathology, 176(3):1433-1442.

Soll, C; Jang, J H; Riener, M O; Moritz, W; Wild, P J; Graf, R; Clavien, P A (2010). Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology, 51(4):1244-1254.

Wild, P J; Fuchs, T; Stoehr, R; Zimmermann, D; Frigerio, S; Padberg, B; Steiner, I; Zwarthoff, E C; Burger, M; Denzinger, S; Hofstaedter, F; Kristiansen, G; Hermanns, T; Seifert, H H; Provenzano, M; Sulser, T; Roth, V; Buhmann, J M; Moch, H; Hartmann, A (2009). Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis. Cancer Epidemiology Biomarkers & Prevention, 18(6):1798-1806.

Eltze, E; Wild, P J; Wülfing, C; Zwarthoff, E C; Burger, M; Stoehr, R; Korsching, E; Hartmann, A (2009). Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters. European Urology, 56(5):837-847.

Riener, M O; Wild, P J; Soll, C; Knuth, A; Jin, B; Jungbluth, A; Hellerbrand, C; Clavien, P A; Moch, H; Jochum, W (2009). Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. International Journal of Cancer, 124(2):352-357.

Sørensen, K D; Wild, P J; Mortezavi, A; Adolf, K; Tørring, N; Heebøll, S; Ulhøi, B P; Ottosen, P; Sulser, T; Hermanns, T; Moch, H; Borre, M; Ørntoft, T F; Dyrskjøt, L (2009). Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 15(4):1400-1410.

Luu, V D; Boysen, G; Struckmann, K; Casagrande, S; von Teichman, A; Wild, P J; Sulser, T; Schraml, P; Moch, H (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clinical Cancer Research, 15(10):3297-3304.

Otto, W; Denzinger, S; Bertz, S; Gaumann, A; Wild, P J; Hartmann, A; Stoehr, R (2009). No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer. International Journal of Cancer, 125(9):2205-2208.

Dahl, E; En-Nia, A; Wiesmann, F; Krings, R; Djudjaj, S; Breuer, E; Fuchs, T; Wild, P J; Hartmann, A; Dunn, S E; Mertens, P R (2009). Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer, 9:410.

Veeck, J; Wild, P J; Fuchs, T; Schüffler, P J; Hartmann, A; Knüchel, R; Dahl, E (2009). Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer, 9:217.

Fuchs, T J; Haybaeck, J; Wild, P J; Heikenwalder, M; Moch, H; Aguzzi, A; Buhmann, J M (2009). Randomized tree ensembles for object detection in computational pathology. In: Bebis, G; et al. Advances in Visual Computing : 5th International Symposium, ISVC 2009, Las Vegas, NV, USA, November 30 - December 2, 2009, Proceedings, Part 1. Berlin: Springer, 367-380.

Moch, H; Artibani, W; Delahunt, B; Ficarra, V; Knuechel, R; Montorsi, F; Patard, J J; Stief, C G; Sulser, T; Wild, P J (2009). Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. European Urology, 56(4):636-643.

Catto, J W F; Abbod, M F; Wild, P J; Linkens, D A; Pilarsky, C; Rehman, I; Rosario, D J; Denzinger, S; Burger, M; Stoehr, R; Knuechel, R; Hartmann, A; Hamdy, F C (2009). The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. European Urology, 57(3):398-406.

Fuchs, T J; Wild, P J; Moch, H; Buhmann, J M (2008). Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Pt. 2. Berlin: Springer, 1-8.

Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25.

Reschke, M; Mihic-Probst, D; van der Horst, E H; Knyazev, P; Wild, P J; Hutterer, M; Meyer, S; Dummer, R; Moch, H; Ullrich, A (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16):5188-5197.

Riener, M O; Nikolopoulos, E; Herr, A; Wild, P J; Hausmann, M; Wiech, T; Orlowska-Volk, M; Lassmann, S; Walch, A; Werner, M (2008). Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q. Human Pathology, 39(11):1621-1629.

Burger, M; van der Aa, M N M; van Oers, J M M; Brinkmann, A; van der Kwast, T H; Steyerberg, E C; Stoehr, R; Kirkels, W J; Denzinger, S; Wild, P J; Wieland, W F; Hofstaedter, F; Hartmann, A; Zwarthoff, E C (2008). Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. European Urology, 54(4):835-844.

Ingold, B; Wild, P J; Nocito, A; Amin, M B; Storz, M; Heppner, F L; Moch, H (2008). Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Histopathology, 52(6):674-681.

Veeck, J; Chorovicer, M; Naami, A; Breuer, E; Zafrakas, M; Bektas, N; Dürst, M; Kristiansen, G; Wild, P J; Hartmann, A; Knuechel, R; Dahl, E (2008). The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene, 27(6):865-876.

Bektas, N; Haaf, A; Veeck, J; Wild, P J; Lüscher-Firzlaff, J; Hartmann, A; Knüchel, R; Dahl, E (2008). Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer, 8:42.

Fuchs, T J; Lange, T; Wild, P J; Moch, H; Buhmann, J M (2008). Weakly supervised cell nuclei detection and segmentation on tissue microarrays of renal clear cell carcinoma. In: Rigoll, G. Pattern Recognition. Berlin, DE: Springer, 173-182.

Blana, A J; Straub, M A; Wild, P J; Lunz, J C; Bach, T; Wieland, W F; Ganzer, R (2007). Approach to endoscopic extraperitoneal radical prostatectomy (EERPE): the impact of previous laparoscopic experience on the learning curve. BMC Urology, 7:11.

This list was generated on Mon Jun 17 01:13:38 2019 CEST.